Back
Stewart Information Services Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
46
STC
Stewart Information Services
Last Price:
67.92
Seasonality Move:
5.47%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
128.41
Seasonality Move:
9.41%
Sell
46
Stewart Information Services (STC)
is a Sell
Is Stewart Information Services a Buy, Sell or Hold?
- The current Stewart Information Services [STC] share price is $67.97. The Score for STC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- STC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.42. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STC Stock Price Chart
What is Stewart Information Services's stock price today?
-
The Stewart Information Services share price today is $67.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STC is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
STC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.05 | Sell |
| Relative Strength Index (14 RSI): | 38.24 | Sell |
| Chaikin Money Flow: | -1895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69 - 74.42) | Sell |
| Bollinger Bands (100): | (64.04 - 73.42) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | 461520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.97 - 126.81) | Buy |
| Bollinger Bands (100): | (122.4 - 147.1) | Sell |
STC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.14 | Sell |
| 20-day SMA: | 70.85 | Sell |
| 50-day SMA: | 71.9 | Sell |
| 200-day SMA: | 65.24 | Buy |
| 8-day EMA: | 69.24 | Sell |
| 20-day EMA: | 70.41 | Sell |
| 50-day EMA: | 70.79 | Sell |
| 200-day EMA: | 64.81 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.47 | Buy |
| 20-day SMA: | 123.38 | Buy |
| 50-day SMA: | 128.91 | Sell |
| 200-day SMA: | 129.86 | Sell |
| 8-day EMA: | 125.64 | Buy |
| 20-day EMA: | 124.89 | Buy |
| 50-day EMA: | 128.25 | Buy |
| 200-day EMA: | 127.82 | Buy |
Stewart Information Services Earnings Growth & STC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $2.48 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.27 per share, and an increase next year of $8.99 per share.
Stewart Information Services Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||